Shares of Eli Lilly were on the rise on Wednesday after Wall Street learned that the company is seeking FDA clearance for its COVID-19 antibody treatment. The company announced that it has submitted a request to the U.S. Food and Drug Administration for emergency authorization of the drug LY-CoV555. LY-CoV555 belongs to a class of … Continue reading “Eli Lilly Shares Soar After Company Requests FDA Clearance for Antibody Drug”
